Schedule 13G ownership disclosure
Treace Medical Concepts Inc
Common stock, $0.001 par value · CUSIP: 89455T109
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Gagnon Securities LLC
Shares: 3,928,051.00 · Class: 6.2%
- Gagnon Advisors, LLC
Shares: 1,534,034.00 · Class: 2.4%
- Neil Gagnon
Shares: 6,142,107.00 · Class: 9.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019056-26-000033
- Form type
- SCHEDULE 13G/A
- Filer
- GAGNON SECURITIES LLC
- CIK
- CIK 1125725
- Filed
- Feb 12, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership